[속보] AstraZeneca Corona 19 vaccine approved by the Korean Food and Drug Administration… “Vaccination for the elderly over 65”

Input 2021.02.10 14:03

In Korea, approval for a new coronavirus infection (Corona 19) vaccine developed by Oxford University in the UK and AstraZeneca has been decided. It is the first vaccine conditionally licensed in Korea.

The Ministry of Food and Drug Safety (hereinafter referred to as the Ministry of Food and Drug Safety) held a final inspection committee composed of internal and external experts on the 10th, and the Corona 19 vaccine’Korea AstraZenecacovid-19 vaccine’ that AstraZeneca Korea applied for permission on the 4th It said that the approval was decided on the condition of submitting the results of additional clinical trials.

AstraZeneca Corona 19 Vaccine is a virus vector vaccine that is cultured and delivered into human cells after the corona 19 virus surface antigen gene is put into an’adenovirus’ that only infects chimps. The delivered corona antigen gene synthesizes the antigen protein in the body to induce the production of neutralizing antibodies, and when the corona 19 virus enters the human body, it neutralizes and removes the virus.

The efficacy and effect of this drug is the prevention of Corona 19 in people 18 years of age or older, and the usage and dose is 0.5 mL each intramuscularly injected twice within 4 to 12 weeks.

This vaccine is manufactured by commissioning a domestic pharmaceutical company, SK Bioscience, and is the first Corona 19 vaccine to be licensed in Korea. It has received conditional permits or emergency use approvals in 50 countries including Europe (EMA), United Kingdom, Argentina and India.

AstraZeneca vaccination has become possible in Korea as well. The Ministry of Food and Drug Safety said, “The final review committee judged that the safety of the vaccine was generally good.” Compared to, it was similar or low level,” he explained.

However, the Final Inspection Committee commented that it is necessary to monitor the occurrence of abnormal cases related to the nervous system, including transverse myelitis, after permission, and plans to additionally reflect such abnormal cases to be reported in the future.